The firm said the studies, which are likely to be released in 2026 and 2027, "are likely to support" FDA approval for GLP-1 drugs in the treatment of cardiovascular diseases
Congratulations to Team Alkem launching first pre filled Semaglutide injection.It will definitely take the market share, convenient for patients as per price and easy to use
While oxidative stress contributes to cancer progression, understanding the complex interplay between obesity-induced metabolic changes and redox signaling in triple negative breast cancer (TNBC) presents a unique opportunity to develop targeted therapeutic strategies for this historically treatment-resistant disease.In this dissertation, we aimed to understand how obesity and TNBC, both as metabolic diseases, affect lipid-specific oxidative stress in the context of tumor metabolism and response to current front-line therapies
engineered a dendritic polymer to mitigate liver inflammation and foster hepatic regeneration [209]
Aso Y, Terasawa T, Kato K, Jojima T, Suzuki K, Iijima T, Kawagoe Y, Mikami S, Kubota Y, Inukai T, Kasai K
